Day: August 19, 2022

Total Revenue up 52%, Driving 51% Increase in Gross Profit and 34% Increase in Adjusted EBITDA CHANDLER, Ariz., Aug. 19, 2022 (GLOBE NEWSWIRE) — VirTra, Inc. (NASDAQ: VTSI) (“VirTra”), a global provider of judgmental use of force training simulators and firearms training simulators for the law enforcement and military markets, reported results for the second quarter and six months ended June 30, 2022. The financial statements are available on VirTra’s website and here. Second Quarter 2022 Financial Highlights:Total revenue increased 52% to $8.0 million Gross profit increased 51% to $4.7 million, or 59% of total revenue Net income increased to $787,000 Adjusted EBITDA increased to $1.3 million Backlog at June 30, 2022 of $16.5 million Working capital surplus totaled $27.0 million, including unrestricted cash and cash equivalents...

NANJING, China, Aug. 19, 2022 (GLOBE NEWSWIRE) — Ostin Technology Group Co., Ltd. (the “Company”) (Nasdaq: OST), a supplier of display modules and polarizers in China, today reported its unaudited financial results for the six months ended March 31, 2022. Half-Year Ended March 31, 2022 Summary:Revenue declined by 31% to $60.09 million for the six months ended March 31, 2022, from $87.37 million for the same period in 2021; Gross margin grew to 14% for the six months ended March 31, 2022, from 12% for the same period in 2021; Operating income decreased by 23% year-over-year to $1.63 million for the six months ended March 31, 2022, from $2.13 million for the same period in 2021;   Net income was $1.20 million for the six months ended March 31, 2022, compared to $1.45 million for the same period in 2021; Earnings per...

ORLANDO, Fla., Aug. 19, 2022 (GLOBE NEWSWIRE) — Kalera Public Limited Company (Nasdaq: KAL, “Kalera” or the “Company”), a vertical farming company, today reported its financial results for the second quarter ended June 30, 2022. Second Quarter Financial OverviewTotal revenue of $1.3 million, marking an increase of $0.8 million from the second quarter last year:Foodservice revenue of $0.8 million, an increase of $0.6 million; Retail revenue of $0.5 million, an increase of $0.2 million.Net loss of $78.7 million, or a loss of $3.92 per diluted share, which included a one-time non-cash expense for goodwill impairment of $64.3 million, the change in fair value for the contingent value rights earnout of $17.3 million and a one-time expense of $7.5 million related to the closing of the Agrico business combination and Nasdaq listing. Adjusted...

TULIKIVI CORPORATION  HALF YEAR FINANCIAL REPORT  19 AUGUST 2022 AT 1 PM Tulikivi Corporation                                             Half year financial report 1–6/2022: Higher net sales, better operating profit and significantly stronger order books – The Tulikivi Group’s net sales were EUR 12.2 million (EUR 9.3 million, 4–6/2021) in the second quarter and EUR 20.6 million (EUR 15.8 million, 1–6/2021) in the review period.– The Tulikivi Group’s operating profit was EUR 1.7 (1.1) million in the second quarter and EUR 2.0 (1.1) million in the review period. – The Tulikivi Group’s profit before taxes was EUR 1.4 million (1.0 million) in the second quarter and EUR 1.5 (0.8) million in the review period. – Net cash flow from operating activities was EUR 1.6 (1.1) million in the second quarter and EUR 2.2...

07:45 London, 09:45 Helsinki, 19 August 2022 – Afarak Group Plc (“Afarak” or “the Company”) (LSE: AFRK, NASDAQ: AFAGR) FINANCIAL INTERIM RELEASE H1 2022    H1/22 H1/212021Revenue EUR million 92.1 37.3 80.3EBITDA EUR million 24.5 -0.9 5.9EBIT EUR million 24.0 0.9 6.8Earnings before taxes EUR million 22.6 -0.5 2.9Profit from continuing operations EUR million 21.2 -0.9 0.6Profit from discontinuing operations EUR million 2.9 0.0 8.4Profit EUR million 24.1 -0.9 9.0Earnings per share EUR 0.10 0.00 0.04EBITDA margin % 26.7 -2.4 7.4EBIT margin % 26.1 2.4 8.5Earnings margin % 24.6 -1.3 3.6Personnel (end of period)   549 608 503FIRST HALF 2022 HIGHLIGHTSRevenue increased strongly by 146.5% to EUR 92.1 (H1/2021: 37.3) million; Processed material sold increased by 24.2% to...

Oslo, August 19, 2022: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announces its second quarter 2022 results today. The presentation by the company’s management team can be followed as a live webcast at 09:00 CET and will be made available on the website. It will be possible to post questions during the presentation through the webcast. Highlights of Second Quarter 2022 and Recent Business, Clinical and Research ProgressOn 30 June 2022, Ultimovacs completed the planned recruitment of 154 patients in the INITIUM trial. Two additional patients were enrolled in July 2022, bringing the final number of patients enrolled to 156. Consistent with INITIUM’s event-driven design, topline progression-free survival results will be disclosed after progression of cancer...